vTv Therapeutics Schedules KOL Event on Type 1 Diabetes Therapy

vTv Therapeutics Inc. (NASDAQ:VTVT) will host a virtual key opinion leader (KOL) event on October 20, 2026, to discuss hypoglycemia in type 1 diabetes and its cadisegliatin Phase 3 program.